Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Redwood City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Jasper Therapeutics, Inc. has filed 456 SEC EDGAR filings since 13 Sep 2019

SEC filing history

Showing 201-225 of 456 matching filings.

Per page
25
Current page
9
S-3 File 333-271500

REGISTRATION STATEMENT

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39138

FORM ARS

Filing date
21 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39138

DEFINITIVE ADDITIONAL MATERIALS

Filing date
21 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39138

DEFINITIVE PROXY STATEMENT

Filing date
21 Apr 2023
Reporting date
07 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39138

144 filing

Filing date
14 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Apr 2023
Reporting date
14 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Apr 2023
Reporting date
13 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Apr 2023
Reporting date
13 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
14 Apr 2023
Reporting date
13 Apr 2023
Next action
Verify source filing
144 File 001-39138

144 filing

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39138

144 filing

Filing date
13 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Apr 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39138

PRELIMINARY PROXY STATEMENT

Filing date
10 Apr 2023
Reporting date
10 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2023
Reporting date
17 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2023
Reporting date
17 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270361

REGISTRATION STATEMENT

Filing date
08 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39138

ANNUAL REPORT

Filing date
08 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
08 Mar 2023
Reporting date
08 Mar 2023
Next action
Verify source filing
3/A

3/A filing

Filing date
27 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91228

SCHEDULE 13D

Filing date
27 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39138

CURRENT REPORT

Filing date
17 Feb 2023
Reporting date
16 Feb 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .